Danaher (DHR)
(Delayed Data from NYSE)
$269.23 USD
+0.42 (0.16%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $269.07 -0.16 (-0.06%) 5:20 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$269.23 USD
+0.42 (0.16%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $269.07 -0.16 (-0.06%) 5:20 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Zacks News
Top Stock Reports for Tesla, Broadcom & Anthem
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Broadcom Inc. (AVGO), and Anthem, Inc. (ANTM).
Danaher (DHR) Exhibits Bright Prospects, Headwinds Persist
by Zacks Equity Research
Danaher (DHR) gains from solid demand for its products, acquired assets and shareholder-friendly policies. However, escalating costs and high debt levels remain concerns.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $245.91 in the latest trading session, marking a +0.84% move from the prior day.
Danaher (DHR) Stock Moves -1.67%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $240.85, moving -1.67% from the previous trading session.
MARUY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MARUY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $263.74, moving -0.87% from the previous trading session.
Why Is ITT (ITT) Down 5.5% Since Last Earnings Report?
by Zacks Equity Research
ITT (ITT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MARUY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
MARUY vs. DHR: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing
by Zacks Equity Research
Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing are part of Zacks Top Analyst Blog.
Top Analyst Reports for Adobe, Danaher, Equinor & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Danaher Corporation (DHR), and Equinor ASA (EQNR).
Top Analyst Reports for Alphabet, Amazon & Chevron
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Amazon.com, Inc. (AMZN), and Chevron Corporation (CVX).
All You Need to Know About Danaher (DHR) Rating Upgrade to Buy
by Zacks Equity Research
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Danaher's (DHR) Q1 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Danaher's (DHR) first-quarter 2022 revenues increase 12% year over year driven by impressive performance across its segments.
Danaher (DHR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 4.15% and 1.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights UnitedHealth Group, Danaher, Wells Fargo, Vertex Pharmaceuticals and Canadian Pacific Railway
by Zacks Equity Research
UnitedHealth Group, Danaher, Wells Fargo, Vertex Pharmaceuticals and Canadian Pacific Railway have been included in this Analyst Blog.
Q1 Scorecard and Analyst Reports for UnitedHealth, Danaher & Wells Fargo
by Sheraz Mian
Today's Research Daily features Q1 earnings season scorecard and fresh reports on UnitedHealth(UNH), Danaher (DHR), Wells Fargo (WFC) & others.
Danaher (DHR) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Danaher's (DHR) Q1 earnings are likely to have benefited from better-than-expected performances across its Diagnostics and Life Sciences segments. Cost inflation might have dragged its margins.
5 Perfect Earnings Charts
by Tracey Ryniec
It's not easy to beat every quarter for 5 years, especially during a pandemic. These 5 companies are earnings all-stars.
SSUMY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
SSUMY vs. DHR: Which Stock Is the Better Value Option?
LSB (LXU) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
LSB (LXU) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Danaher (DHR) Stock Moves -1.36%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $293.33, marking a -1.36% move from the previous day.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $287.53 in the latest trading session, marking a +0.35% move from the prior day.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $286.53, moving +0.17% from the previous trading session.
The Zacks Analyst Blog Highlights Comcast, Danaher, Amgen, Boeing and Canadian Pacific Railway
by Zacks Equity Research
Comcast, Danaher, Amgen, Boeing and Canadian Pacific Railway have been included in this Analyst Blog.
Top Stock Reports for Comcast, Danaher & Amgen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Comcast Corporation (CMCSA), Danaher Corporation (DHR), and Amgen Inc. (AMGN).